A Randomized, Double-Blind, Placebo-Controlled Study of Add-On Ramelteon in Ambulatory Bipolar I Disorder With Clinically Significant Sleep Disturbance.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Ramelteon (Primary)
- Indications Bipolar I disorders; Insomnia
- Focus Therapeutic Use
- 14 Dec 2010 Actual end date changed from Mar 2010 to Dec 2010 as reported by ClinicalTrials.gov.
- 14 Dec 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 01 Dec 2010 Primary endpoint 'Pittsburgh-Sleep-Quality-Index' has not been met
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History